Valentino, M. | Search bioRxiv

bioRxiv2024

Comparative Analysis of Stain-Free Fourier Ptychographic Microscopy and Traditional Histopathological Light Microscopy in Renal Membranous Nephropathy

BackgroundHistology remains a cornerstone in the diagnosis and prognosis of renal diseases, with histopathological analysis of kidney tissue being crucial for understanding renal pathophysiology. The availability of multiple stained sections is essential for conducting a comprehensive histopathological analysis and achieving an accurate diagnosis. Recently, Fourier Ptychographic Microscopy (FPM) earned a spot among the most promising microscopy techniques. The ability to provide high-resolution, quantitative phase-contrast images over a wide area, particularly in a stain-free mode, makes FPM highly appealing to experts in histopathology. Since renal pathologies are characterized by subtle morphological changes encoded in tissue slides, phase maps obtained using FPM are well-suited for providing detailed, high-contrast images of tissue structures. Thus, FPM provides a quantitative imaging tool that can be descriptive of the sample and/or expressive of the disease. MethodsIn this study, we explore FPM capability to image pathological kidney tissue, enabling pathologists to select regions of interest within the intricate architecture of renal tissue and zoom in to observe minute submicron structures, ranging from overall tissue organization and glomeruli distribution to individual cell membranes. Attention is focused on membranous glomerulonephritis since it is a nephropathy highly dependent on histological examination. ResultsThe comparative analysis between FPM and traditional light microscopy showed a difference in thickness of glomerular basal membranes between healthy kidney tissues and those affected by membranous glomerulonephritis (MG). Moreover, the results reported in our investigation revealed better glomerular membranes contrast in FPM images with respect to the H&E-stained images. ConclusionsOur study shows the broad potential of FPM in characterizing hallmarks of MG disease even in stain-free tissue slides.

pathology↗

bioRxiv2024

Sub-clinical glutamate receptor antagonist combinations prevent progressive demyelination.

Multiple sclerosis (MS) affects almost 3 million people globally who suffer demyelination as a series of relapses and remissions that tend towards progressive deterioration over time. The proximate cause is auto-immune attack by the adaptive immune system; therapies directed against this are effective during the relapsing-remitting phase but are less effective or ineffective during progression where other injury mechanisms may be significant. LPS- and cuprizone-induced experimental demyelination share features of progressive demyelination in MS but the underlying mechanisms are not well understood. We show here that these demyelination models can be reproduced ex vivo using short protocols, revealing that combined antagonism of two types of glutamate receptor, NMDA and AMPA, using clinically approved antagonists at sub-clinical doses, can protect against these forms of demyelination. Combined low dose therapy was subsequently shown to be effective in vivo against dietary cuprizone and experimental autoimmune-encephalomyelitis (EAE) models of demyelination and, in particular, protected the smaller myelinated axons that are the main substrate of the function loss in progressive MS.

neuroscience↗